Skip to main content

GHA Issues Advice To Vulnerable Groups In The Event That They Test Positive For COVID-19

08 April 2022
GHA Issues Advice To Vulnerable Groups In The Event That They Test  Positive For COVID-19

The GHA has announced it is writing individually to members of the public who it has identified as vulnerable to serious illness from COVID-19, to advise them of the steps they should take in the event that they  test positive for the virus.  

A statement from the Government follows below:

The GHA is writing individually to members of the public who it has identified as vulnerable to serious illness from COVID-19, to advise them of the steps they should take in the event that they  test positive for the virus.  

Individuals who are vulnerable may benefit from antibody and antiviral treatment if they test  positive. These treatments can help some people manage their COVID-19 symptoms and reduce  the risk of becoming seriously ill. They are for people who have not been admitted to hospital and  are well enough to manage their symptoms at home. 

Individuals who are vulnerable and who test positive for COVID-19 should call 111 immediately. This is important to do as soon as you test positive because some treatments  are effective within 5 or 7 days of onset of COVID-19 infection. 

Individuals may be vulnerable to serious illness from COVID-19 if they have:  

  • Down’s syndrome 
  • Sickle Cell Disease 
  • Current cancer or has received treatment for cancer in the last 12 months (chemotherapy in  past 12 months or radiotherapy in past 6 months)  
  • Leukaemia or lymphoma or myeloma or has had treatment for these or other blood cancers  in the last 12 months or has received a stem cell or bone marrow transplant for any reason.  Other haematological diseases that require immunosuppressant treatment (e.g. aplastic  anaemia, paroxysmal nocturnal haemoglobinuria) 
  • Severe kidney failure, is on dialysis or has had a kidney transplant 
  • Severe liver disease or has had a liver transplant  
  • An immune/ auto-immune disease which is treated with immunosuppressant drugs 
  • A diagnosed immune deficiency syndrome  
  • HIV 
  • Received an organ transplant (heart, lungs, pancreas etc).  
  • One of the following neurological conditions: Multiple sclerosis, Motor neurone disease,  Myasthenia gravis or Huntington’s disease.

Further information for those vulnerable to COVID-19 is available on the Public Health Gibraltar  website: https://healthygibraltar.org/news/sars-cov-2/vulnerable-to-covid-19/ 

The Director of Public Health, Dr Helen Carter, said: ‘It is extremely important for vulnerable  individuals to call 111 as soon as they test positive for COVID-19 so that their case can be reviewed  and appropriate treatment can be arranged for them as soon as possible. This, in addition to  vaccination, will give them the best possible chance of avoiding serious illness.’